ESR1 and obesity disorder: Consistent with this, our previous work demonstrated that DNMT1/3A-mediated methylation at the Esr1 promoter in adipocytes suppresses estrogen receptor expression, thereby promoting adipose tissue inflammation and contributing to obesity-induced insulin resistance in female mice [21].